News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Finance
New Cambridge-Based Biotech VC Firm Remiges BioPharma Emerges, Eyes $150 Million Fund 7/25/2014
Glaucoma Research Foundation Receives $1 Million Bequest From San Francisco Philanthropist Paul S. May 7/25/2014
Theraclion Receives €900 Thousand From Bpifrance's "Industrial Strategic Innovation" Program To Fund Development Of A New Treatment System In Collaboration With Supersonic Imagine 7/25/2014
Atox Bio Locks In $23 Million 7/24/2014
Xention Limited Awarded £1.4m From Technology Strategy Board To Develop New Medicines For Atrial Fibrillation 7/24/2014
Cambridge-Based Broad Institute To Receive Largest Gift Worldwide: $650 Million 7/23/2014
Taiho Pharmaceutical Invests US $30 Million In Remiges Biopharma Fund, LP 7/23/2014
Mela Sciences (MELA) Announces $27.3 Million Private Placement Of Preferred Stock, Debentures And Warrants 7/23/2014
Skystar Bio-Pharmaceutical (CGPN) Of Xi’an Raises $5 Million 7/22/2014
Synlogic Secures $29.4 Million Series A Financing Led By Atlas Venture 7/22/2014
StemCells Inc. (STEM) Announces Closing Of $20 Million Offering 7/21/2014
Phosphagenics Limited (POH.AX) Completes First Tranche of A $19.3 Million Capital Raising 7/21/2014
Cerecor Inc. Closes On Initial Tranche Of US $32 Million Series B Financing 7/21/2014
UrgentRx® Locks In $17.5 Million In Series C Funding 7/17/2014
Infosys Co-founder Kris Gopalakrishnan Donates $1.8 Million To Carnegie Mellon University To Promote Brain Research And Education 7/17/2014
InflaRx Announces Successful Closing Of Its Round B Financing 7/17/2014
Melanoma Research Foundation Release: Senate Appropriations Committee Increases Funding Available For Melanoma Research 7/17/2014
ZS Pharma (ZSPH) Secures $20 Million In Debt Financing 7/17/2014
Menlo Park's Virobay Inc. Completes $8 Million Series B Funding Round 7/16/2014
immatics biotechnologies GmbH Reels In €22 Million Series D 7/16/2014
Virobay Inc. Completes $8 Million Series B Preferred Stock Financing 7/16/2014
Phosphagenics Limited (POH.AX) Locks In $19.3 Million Capital Raising 7/11/2014
TONIX Pharmaceuticals, Inc. Announces Registered Direct Offering Of $7.8 Million 7/11/2014
Ocera Therapeutics, Inc. (OCRX) Raises $25.2 Million In Public Offering 7/10/2014
Fund Manager Dumps Biggest Investment Into AstraZeneca PLC (AZN) 7/9/2014
VC Firm Versant Ventures Closes In On $300 Million Fund For Medtech And Biotech 7/9/2014
National Institutes of Health (NIH) Funds Phase 2 Clinical Trial At University of California, Los Angeles (UCLA) For The Treatment Of ADHD With NeuroSigma, Inc.'s eTNS Systemnational 7/9/2014
DelMar Pharmaceuticals Receives Funding From The Canadian Federal Government 7/9/2014
MabVax Therapeutics, Inc. Raises $3 Million In Common Stock Financing And An Additional $1.5 Million Upon Exercise Of Series C-1 Warrants 7/9/2014
480 Biomedical Awarded $1 Million Phase II NHLBI Contract To Advance Bioresorbable Scaffold For Pediatric Pulmonary Artery Stenosis 7/9/2014
Chromatin, Inc.Secures $12.5 Million Credit Facility With The PrivateBank 7/9/2014
Biosceptre International Limited Closes AUD 5 Million Financing From Existing Investors 7/9/2014
Domainex Ltd Reports Success Of Its Lead Compound In Pre-Clinical Model Of COPD And Secures £1.4 Million Biomedical Catalyst Award 7/9/2014
Supernus Pharmaceuticals (SUPN) To Receive $30 Million In Non-Dilutive Royalty Deal 7/8/2014
National Institutes of Health (NIH) Has A New $248 Million Focus: Electroceuticals 7/7/2014
New York Couple Gifts Cold Spring Harbor Laboratory $50 Million For Biology Center 7/7/2014
Galapagos NV (GLPG.BR) Raises €1.9 Million Through Warrant Exercises 7/7/2014
ProSensa Holding N.V. (RNA) Files F-3 SEC Mixed Shelf Registration For Up To $150 Million 7/7/2014
Advanced Cell Technology Secures $30 Million Financing 7/3/2014
Zurex Pharma, Inc. Nabs $4 Million to Battle Hospital-Acquired Infections 7/3/2014
Akashi Therapeutics Receives Collective Funding Of $1.5 Million To Support HT-100 Clinical Development 7/3/2014
Retrophin, Inc. (RTRX) Snags $91 Million 7/2/2014
Novato's Raptor Pharmaceutical Inc. (RPTP) Reels In $70 Million 7/2/2014
Massachusetts Startup Synchroneuron Nets $20 Million To Fund SNC-102 For Neuropsychiatric Disorders 7/2/2014
Oxford Finance and Solar Capital Close $30 Million Senior Debt Facility With Radius (RDUS) 7/2/2014
AstraZeneca PLC (AZN) CEO Wagers $3.4 Million On Shares 7/1/2014
Menlo Park's Emerald Therapeutics Completes Latest Financing, Brings Total To $13.5 Million 7/1/2014
South San Francisco's Tobira Therapeutics Inc. Wraps Up $15 Million Loan Agreement 7/1/2014
TrovaGene, Inc. Secures $15 Million In Debt Financing From Trojantec Ltd. And Oxford Finance 7/1/2014
Sorrento Therapeutics, Inc. Awarded Up To $2.6 Million From The National Institutes of Health (NIH) For The Development Of New Anti-Bacterial Bispecific Antibodies And Antibody Formulated Drug Conjugates 7/1/2014
Karo Bio AB Granted 3.8 MSEK From Vinnova 7/1/2014
uniQure Secures Additional $10 Million Venture Loan From Hercules Capital 7/1/2014
Confirmed: With $32 Million, Boston Startup Morphs Into San Diego's Cidara Therapeutics 7/1/2014
Shire Gets $248 Million Tax Refund From Canada, More To Come 6/30/2014
To-BBB technologies BV Scrounges Up Euro 10 Million 6/30/2014
DURECT Corporation (DRRX) Secures $20 Million Debt Financing 6/27/2014
Biotech-Focused VC Firm Polaris Targets $400 Million For 7th Fund 6/27/2014
Actavis (ACT) Dumps $18 Million In New Warehouse Facilities 6/27/2014
SiEnergy Systems, LLC Awarded $2.65 Million As Part Of ARPA-E’s REBELS Program To Develop Innovative Distributed Generation Technologies 6/27/2014
Eighteen French Biotechs Such As Genticel And Genomic Vision Trek To New York To Hunt For American Investors 6/26/2014
Cytomedix Inc. (CMXI) Completes The Second Tranche Of The $35 Million Convertible Debt Financing With Deerfield Management Company 6/26/2014
Manchester's 4D Pharma Reels In $29 Million 6/26/2014
Biotech Fraud-Detection Firm BioCatch Bags $10 Million In Funding 6/26/2014
HedgePath Pharmaceuticals Secures Interim Financing To Commence Clinical Trials And Finalizes Key Agreement With Mayne Pharma Limited 6/25/2014
CrystalGenomics Nabs $12.8 Million From The Global Pharmaceutical Industry Development Fund 6/25/2014
Backed By New Investors Such As Lilly Ventures, Bay Area's Numerate Secures $8 Million 6/24/2014
TetraLogic Pharmaceuticals (TLOG) Announces Closing Of $47 Million Convertible Senior Notes Offering 6/24/2014
Transition Therapeutics Inc. (TTH.TO) Announces Closing Of Private Placement Equity Financing 6/23/2014
Oxitec Completes Oversubscribed £6.1 Million ($10.2 Million) Fundraising To Commercialise Pioneering Dengue Mosquito Control Technology 6/23/2014
Cambridge Startup Dimension Therapeutics Reels In $30 Million Financing 6/23/2014
Los Angeles' Genzum Life Sciences Reels In $20 Million In Funding 6/20/2014
Cambridge Startup Navitor Pharmaceuticals Debuts With $23.5 Million Series A In Pocket 6/20/2014
Dr. Reddy's Laboratories Ltd. (RDY) To Dump $320 Million In Biologics, Proprietary Medicines 6/20/2014
Sidney Kimmel Foundation Gives $110 Million To Jefferson Medical College Of Thomas Jefferson University 6/19/2014
Tyrogenex, Inc. Nabs $15 Million Series D Financing 6/19/2014
JHL Biotech Locks In $35 Million Series B Financing 6/19/2014
Horizon Biopharm In $300 Million Credit Agreement For Vidara Therapeutics Buy 6/19/2014
TetraLogic Pharmaceuticals (TLOG) Announces Pricing Of $47 Million Offering Of Convertible Notes 6/18/2014
Lakewood-Amedex Inc. Raises $5.5 Million In Series C Preferred Stock Financing 6/18/2014
Valeant Pharmaceuticals International (VRX) Commences Exchange Offer For Allergan Inc. (AGN) 6/18/2014
Western Oncolytics Receives $275,000 Seed Funding For Development Of Cancer Immunotherapy 6/18/2014
South San Francisco's True North Therapeutics Reels In $22 Million Series A Financing 6/18/2014
AuraSense Therapeutics Completes $13.6 Million Series C Equity Investment 6/17/2014
BioTime (BTX) Subsidiary Asterias Biotherapeutics Announces Investment By CEO 6/17/2014
BioTime (BTX) Subsidiary Asterias Biotherapeutics Raises $13.0 Million In Equity Financing 6/17/2014
Relmada Therapeutics Successfully Completes Offerings Totaling $28 Million In Connection With Going Public Transaction 6/16/2014
BrainStorm Cell Therapeutics Inc. Raises $10.5 Million In Private Placement Financing 6/13/2014
CannLabs, Announces Reverse Merger And Commitment Of $1.25 Million In Funding 6/13/2014
Berkeley's Aduro Biotech Reels In $55 Million Series C Financing 6/13/2014
Health Integrated Secures $4 Million In Venture Debt Financing From Western Technology Investment 6/12/2014
Cortexyme Raises Seed Funding, Awarded Breakout Labs Investment 6/12/2014
Clarus Therapeutics Locks In $31.5 Million 6/12/2014
Merus Labs International Inc. Announces Aggregate $21 Million Financing Transactions 6/11/2014
BioSilta Completes EUR 2.5 Million ($3.4 Million) Funding Round 6/11/2014
Oxford Finance Closes $4 Million Debt Facility With IntelliCyt Corporation 6/11/2014
RuiYi (formerly Anaphore) Closes $4 Million Venture Loan From Silicon Valley Bank 6/11/2014
As Its Investors Reap Returns, San Francisco's Venbio Aims For A Bigger Second Fund 6/10/2014
Transition Therapeutics Inc. (TTH.TO) Enters Into Deal With Investors To Receive Up To $30.8 Million 6/6/2014
Nordic Nanovector Intends To Undertake Private Placement Of NOK 150 Million 6/6/2014
Cytori Therapeutics, Inc. (CYTX) Closes Previously Announced $10 Million Offering 6/6/2014
Its First Drug In Clinic, Kineta Inc. Keeps Raising Cash From Odd Sources 6/5/2014
“Grindeks” Invests 2.4 Million Euros In Quality Control Laboratory 6/5/2014
Complexa Wraps Up $13 Million Series B Financing Round 6/4/2014
SteadyMed Announces Raise Of $19.6 Million In Preferred Stock Financing 6/4/2014
Clinical Stage Biotech Trevi Therapeutics Brings In $25 Million Series B Financing 6/4/2014
KemPharm, Inc. Bags $60 Million 6/3/2014
Nanotherapeutics Secures $30 Million Loan 6/3/2014
NeoStem, Inc. Accesses $30 Million Equity Facility With Aspire Capital 6/3/2014
Nuvilex (NVLX) Now Has Access To $50 Million With New Banking Agreement 6/2/2014
DefiniGEN Announces Closing Of £2.3 Million ($3.8 Million) Series A Fundraising 6/2/2014
Relypsa, Inc. (RLYP) Secures Loan Facility Of Up To $35 Million 6/2/2014
Jubilant Pharma To Raise Over $100 Million, Plans To Consolidate Pharma Biz 6/2/2014
Retrophin, Inc. (RTRX) Signs A $80 Million Term Loan And Convertible Note Issuing 5/30/2014
Cambridge-Based Biotech Rodin Therapeutics Snags $12.9 Million Series A Financing 5/30/2014
ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) (QGLY) Establishes 3.0 Million Share Equity Line 5/30/2014
Cytori Therapeutics, Inc. (CYTX) To Raise $10 Million In Registered Direct Offering 5/30/2014
VC Firm Epidarex Capital Unveils £47.5 Fund For Early-Stage UK Startups, Spinouts 5/29/2014
Evoke Pharma, Inc. Secures $4.5 Million Loan Facility With Square 1 Bank 5/29/2014
Tarsa Therapeutics Reels In $7 Million To Prepare For Filing NDA For Ostora 5/29/2014
Redwood City Biotech ARMO BioSciences Locks Down $30 Million Series B 5/29/2014
Children's Hospital of Philadelphia Gene-Therapy Spinout Spark Therapeutics Hauls In $72.8 Million 5/29/2014
Bay Area's Twist Bioscience Secures $31.1 Million 5/28/2014
San Francisco Biotech Startup Nurix Taps $25.1 Million Financing 5/27/2014
OXiGENE (OXGN) Announces $16 Million At-The-Market Registered Direct Offering 5/23/2014
Crown Bioscience, Inc. Raises $26.6 Million In Series D Round 5/23/2014
Mucosis B.V. Receives Financial Support From The Dutch Government For Its Syngem® Program 5/22/2014
Lanthio Pharma Receives Dutch Government Loan Of Up To €3.6 Million To Develop Novel Therapy For Lung Fibrosis 5/21/2014
Roche (RHHBY) To Invest $135 Million Into Two New Manufacturing Facilities 5/21/2014
Gene Therapy Biotech Lysogene Reels In $22 Million 5/21/2014
Landmark Gift Of $100 Million From The Marie-Josée And Henry R. Kravis Foundation Will Support Groundbreaking Approach To Precision Oncology At Memorial Sloan-Kettering Cancer Center 5/20/2014
Redwood City's Coherus Biosciences Locks In $55 Million Series C 5/20/2014
Chimerix, Inc. (CMRX) Looks To Rally Up $60 Million Partly To Pay For Drug Trial With Josh Hardy 5/20/2014
AmerisourceBergen Corporation (ABC) Okays Special $650 Million Special Share Repurchase Program 5/19/2014
Proteon Therapeutics, Inc. Announces $45 Million Of Series D Financing 5/16/2014
Gelesis Expands Team To Advance Further Clinical Development Of Its Novel Obesity & Diabetes Therapy & Discloses Recent $12 Million Funding 5/16/2014
Kymab Locks Down $40 Million For Antibody Research 5/16/2014
Sorbent Therapeutics, Inc. Closes $15 Million In First Tranche Of Series D 5/15/2014
Milestone Scientific (MS) Completes $10 Million Financing With A European Investing Group Specializing In High Potential Opportunities 5/15/2014
Xellia Pharmaceuticals Expands Croatian Product And Innovation R&D Center Of Excellence With Investment Of US$2.0 Million 5/14/2014
Transcept Pharmaceuticals, Inc. (TSPT) Declares Special Cash Dividend Of $25 Million 5/14/2014
Chase Pharmaceuticals Raises $21 Million In Series B Financing 5/13/2014
Gemmus Pharma Closes $3.3M Series B Funding To Develop Superior Flu Drug 5/13/2014
Nordic Nanovector: Conversion Of MNOK 25 Convertible Loan 5/13/2014
Lysosomal Therapeutics Inc. Receives $4.8 Million In Seed Funding 5/12/2014
Immunomedics, Inc. (IMMU) Closes $30 Million Public Offering Of Common Stock 5/8/2014
Lophius Biosciences GmbH Secures EUR 2,0 Million Financing And Announces Leadership Changes 5/8/2014
California's Arcadia Biosciences, Inc. Raises $33 Million Series D 5/8/2014
Gilead Sciences, Inc. (GILD) Will Buy Back Another $5 Billion Of Shares 5/8/2014
Livzon Mabpharm Leads $36 Million Funding Of Epirus, A U.S. Biosimilar Co. 5/7/2014
Celgene Corporation (CELG) Prices $2.5 Billion Of Senior Unsecured Notes 5/7/2014
Big Names Infuse Startup Anokion With $37.5 Million 5/7/2014
Connecticut Startup Loxo Oncology Reels In $24 Million Series B 5/6/2014
CryoTherapeutics GmbH Completes An Extension To Its Series A Financing Round Bringing The Total To EUR 6.5 Million 5/6/2014
BioTime (BTX) Raises $6.4 Million In Equity Financing 5/5/2014
Immunomedics, Inc. (IMMU) Prices $30 Million Public Offering Of Common Stock 5/2/2014
Newbie Lightstone Ventures Closes Life Sciences Fund At $172 Million 5/1/2014
Orexo AB (ORXOF) Issues A SEK 500 Million Bond Loan On The Swedish Bond Market 4/30/2014
Rich Pharmaceuticals Provides Financing Update 4/30/2014
IntelGenx Corp. Announces Government Of Canada Funding For CNS Versafilm™ Project 4/30/2014
Otonomy, Inc. Bags $49 Million To Advance Three Ear Disease Drugs 4/30/2014
InnaVirVax: Bpifrance Provides Funding For The PROTHEVIH Program On The Therapeutic Vaccine VAC-3S 4/29/2014
Sunshine Biopharma, Inc. Secures Funding For Its Adva-27a Anticancer Compound From Dutchess Opportunity Fund II 4/29/2014
Voluntis Raises € 20.75 Million ($ 29 Million) 4/28/2014
Verdezyne, Inc. Nabs $48 Million Financing 4/28/2014
Kite Pharma, Inc. Reels In $50 Million Private Financing 4/28/2014
Alimera Sciences (ALIM) Secures $35 Million Debt Facility 4/25/2014
Tauriga Sciences Inc. (TAUG) Aggregate Private Placement Proceeds Exceed $1,100,000 USD Priced At 6 Cents Per Share 4/24/2014
Isarna Therapeutics Raises Euro 5.5 Million, Announces Elizabeth Czerepak Joining As CFO/CBO To Lead U.S. Site 4/24/2014
Startup CRISPR Therapeutics Nabs $25 Million Series A , Forms A World-Renowned Team Of Academics And Clinicians 4/24/2014
Cancer-Fighter Juno Therapeutics Completes $176 Million Series A Round 4/24/2014
Two San Francisco Startups, Element Science And Nurix, Reap Cash From Third Rock Ventures' Rich Funding Round 4/24/2014
Aerpio Closes $22 Million Financing 4/23/2014
Massachusetts' Kala Pharmaceuticals Nabs $22.5 Million More For Eye Drugs 4/23/2014
Neos Therapeutics Announces $20 Million Loan Facility And Updated Total Of $18 Million For Its Additional Series C Financing 4/23/2014
Bay Area's Principia Biopharma Secures $50 Million Series B Financing 4/22/2014
Menlo Park's Avalanche Biotechnologies Secures $55 Million 4/22/2014
Pharming Group (PHGUF.PK) Announces ("Sub 10%") €14.7 Million Private Equity Placement With Institutional Investors 4/22/2014
ProNAi Therapeutics, Inc. Banks $59.5 Million Series D To Fund Non-Hodgkin's Lymphoma Studies 4/22/2014
DARA BioSciences, Inc. Files To Raise $32 Million For Specialty Pharma 4/21/2014
Oxford Finance And Midcap Financial Close $20 Million Senior Credit Facility With Zafgen 4/18/2014
UK Authortity To Spend £18.7 Million To Make Gilead Sciences, Inc. (GILD)'s Sovaldi Available To Most Grave Patients 4/18/2014
Johnson & Johnson (JNJ) Starts Construction On $300 Million China Plant 4/18/2014
VCs Wager $243 Million On San Diego Startups In Q1 4/18/2014
Nora Therapeutics Announces $18 Million Series B Financing 4/17/2014
Oxford Finance And Silicon Valley Bank Expand Existing Senior Credit Facility With Sorrento Therapeutics, Inc. To $12.5 Million 4/17/2014
CEL-SCI (CVM) Announces Closing Of Public Offering For Gross Proceeds Of $10 Million 4/17/2014
Startup Heart Metabolics Limited Launches With $20 Million In Pocket 4/17/2014
Orflo Raises $3.0 Million Of Growth Capital To Support Continued Expansion 4/17/2014
Wilson Therapeutics Bags $40 Million To Advance Late Stage Development Program For Wilson's Disease 4/16/2014
OxThera, Inc. Receives SEK 70 Million Financing To Continue Its Key Clinical Programs 4/16/2014
Nexvet Announces $31.5 Million Financing 4/16/2014
Iconic Therapeutics, Inc. Nabs $20 Million For Wet AMD Program 4/16/2014
Boston-Based EPIRUS Biopharmaceuticals Reels In $36 Million Series B, Will Merge With Zalicus Inc. (ZLCS) In All-Stock Deal 4/16/2014
Benitec Biopharma Wraps Up $29 Million+ Funding Round 4/15/2014
Startup AAVLife Emerges From Stealth Mode With $12 Million In Pocket 4/15/2014
New Jersey's PanOptica, Inc. Reels In $45 Million To Fund Development Of Wet AMD Eye Med 4/15/2014
New Jersey's Elite Pharmaceuticals, Inc. (ELI) Bags $40 Million 4/14/2014
CEL-SCI (CVM) Prices $10 Million Public Offering Of Common Stock And Six Month Warrants 4/14/2014
Spinifex Pharmaceuticals Bags $45 Million To Fund Pain Drug Trials, Established U.S. Base In Connecticut 4/11/2014
NuCana Hauls In $57 Million 4/11/2014



//-->